No Data
No Data
J.P. Morgan Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $45
Ionis Pharmaceuticals Price Target Lowered to $45 From $47 at JPMorgan
Why Is Ionis Pharmaceuticals (IONS) Up 0.1% Since Last Earnings Report?
Is Ionis Pharmaceuticals (NASDAQ:IONS) Weighed On By Its Debt Load?
Ionis Pharmaceuticals: Strategic Partnerships and Financial Flexibility Drive Buy Rating
Express News | Ionis Pharmaceuticals Inc : Leerink Partners Raises Target Price to $55 From $52
Unlock the Full List